BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 679189)

  • 41. The expression of mRNA for glucocorticoid receptor gene and functional glucocorticoid receptors detected in PA-III rat prostate adenocarcinoma cells.
    Koutsilieris M; Grondin F; Lehoux JG
    Anticancer Res; 1992; 12(3):899-904. PubMed ID: 1622147
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Molecular cloning and functional study of rat estrogen receptor-related receptor gamma in rat prostatic cells.
    Lui K; Huang Y; Choi HL; Yu S; Wong KB; Chen S; Chan FL
    Prostate; 2006 Nov; 66(15):1600-19. PubMed ID: 16927302
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of androgen, estrogen (ER alpha and ER beta), and progesterone receptor expression in human prostate cancer by real-time quantitative reverse transcription-polymerase chain reaction assays.
    Latil A; Bièche I; Vidaud D; Lidereau R; Berthon P; Cussenot O; Vidaud M
    Cancer Res; 2001 Mar; 61(5):1919-26. PubMed ID: 11280747
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Prognostic value of the level of steroid hormone receptors in cancer of the large intestine].
    Bassalyk LS; Korotkova TV; Prorokov VV; Murav'eva NI; Smirnova KD
    Vopr Onkol; 1987; 33(9):43-6. PubMed ID: 3660756
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Importance of determining steroid hormone receptors and the treatment of prostatic cancer].
    Fedotov IA; Denisov LE; Kozlov VP; Degtiar' VG
    Urol Nefrol (Mosk); 1983; (1):63-70. PubMed ID: 6187115
    [No Abstract]   [Full Text] [Related]  

  • 46. Characterization of the Dunning R3327H prostatic adenocarcinoma: an appropriate animal model for prostatic cancer.
    Smolev JK; Heston WD; Scott WW; Coffey DS
    Cancer Treat Rep; 1977; 61(2):273-87. PubMed ID: 872132
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Primary and transplantable adenocarcinomas of the A times C rat ventral prostate gland: morphologic characterization and examination of C19-steroid metabolism by early-passage tumors.
    Shain SA; McCullough B; Nitchuk WM
    J Natl Cancer Inst; 1979 Feb; 62(2):313-22. PubMed ID: 84089
    [No Abstract]   [Full Text] [Related]  

  • 48. Inhibition of SULT2B1b expression alters effects of 3beta-hydroxysteroids on cell proliferation and steroid hormone receptor expression in human LNCaP prostate cancer cells.
    He D; Falany CN
    Prostate; 2007 Sep; 67(12):1318-29. PubMed ID: 17626250
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Histochemistry of steroid receptors in prostatic diseases.
    Pertschuk LP; Zava DT; Gaetjens E; Macchia RJ; Wise GJ; Kim DS; Brigati DJ
    Ann Clin Lab Sci; 1979; 9(3):225-9. PubMed ID: 380450
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Steroid receptors and hormone responsiveness of human prostatic carcinoma.
    Concolino G; Marocchi A; Margiotta G; Conti C; Di Silverio F; Tenaglia R; Ferraro F; Bracci U
    Prostate; 1982; 3(5):475-82. PubMed ID: 6216468
    [No Abstract]   [Full Text] [Related]  

  • 51. A stroma targeted therapy enhances castration effects in a transplantable rat prostate cancer model.
    Johansson A; Jones J; Pietras K; Kilter S; Skytt A; Rudolfsson SH; Bergh A
    Prostate; 2007 Nov; 67(15):1664-76. PubMed ID: 17854058
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Cell receptors and the action mechanism of steroid hormones (author's transl)].
    Saez S; Bertrand J
    Lyon Med; 1976 Sep; 236(13):47-70. PubMed ID: 790026
    [No Abstract]   [Full Text] [Related]  

  • 53. [Analyses of steroid hormone receptors in human kidney neoplasms. A molecular biological contribution to the hormone therapy of hypernephroid kidney carcinoma].
    Maar K
    Fortschr Med; 1980 Aug; 98(30-31):1169-72. PubMed ID: 7419161
    [No Abstract]   [Full Text] [Related]  

  • 54. [Steroid receptors in benign prostatic hyperplasia and prostatic cancer].
    Andersson L; Ekman P; Gustafsson JA; Högberg B; Pousette A; Snochowski M
    Lakartidningen; 1977 Dec; 74(52):4673-5. PubMed ID: 73635
    [No Abstract]   [Full Text] [Related]  

  • 55. Human prostatic carcinoma: significant differences in its androgen binding and metabolism compared to the human benign prostatic hypertrophy.
    Krieg M; Grobe I; Voight KD; Altenähr E; Klosterhalfen H
    Acta Endocrinol (Copenh); 1978 Jun; 88(2):397-407. PubMed ID: 78653
    [No Abstract]   [Full Text] [Related]  

  • 56. Characterization and comparison of the estrogen and androgen receptors from the R-3327 rat prostatic adenocarcinoma.
    Markland FS; Lee L
    J Steroid Biochem; 1979 Jan; 10(1):13-20. PubMed ID: 513713
    [No Abstract]   [Full Text] [Related]  

  • 57. [Biochemistry of steroid hormone receptors].
    Gustafsson JA
    Lakartidningen; 1977 Dec; 74(52):4667-9. PubMed ID: 592942
    [No Abstract]   [Full Text] [Related]  

  • 58. Measurement and characterization of estrogen receptors in the human prostate.
    Bashirelahi N; Kneussl ES; Vassil TC; Young JD; Sanefugi H; Trump B
    Prog Clin Biol Res; 1979; 33():65-84. PubMed ID: 93752
    [No Abstract]   [Full Text] [Related]  

  • 59. [Hormone receptors of the hypothalamus and their feedback mechanism of steroid hormones].
    Kato J
    Nihon Rinsho; 1976 Dec; 34(12):3522-34. PubMed ID: 798046
    [No Abstract]   [Full Text] [Related]  

  • 60. Prostatic cancer--immunohistochemistry of steroid hormone receptors.
    Wernert N; Seitz G
    Curr Top Pathol; 1991; 83():475-94. PubMed ID: 2007339
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.